BRONXCARE HEALTH SYSTEM
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.6M
- Transactions
- 147
- Companies
- 25
- Average per transaction
- $10,996
Who reported the payments
| Pfizer | $725,121 |
| Gilead | $556,783 |
| Align Technology, Inc. | $104,460 |
| Sanofi Pasteur Inc. | $93,840 |
| Johnson & Johnson | $25,280 |
| Alcon | $22,846 |
| Global Blood Therapeutics, Inc. | $17,887 |
| Sanofi US Services Inc. | $15,358 |
| Stryker | $12,671 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $12,256 |
| Tandem Diabetes Care, Inc. | $10,050 |
| GE HealthCare | $5,252 |
| Medline Industries LP | $4,918 |
| Bio-rad Laboratories, Inc. | $3,014 |
| Merck | $1,636 |
| KARL Storz Endoscopy-america | $1,530 |
| Siemens Medical Solutions USA, Inc. | $1,353 |
| Medtronic | $500 |
| Convatec Inc. | $467 |
| Insulet Corporation | $350 |
| Welch Allyn | $347 |
| Cochlear Americas | $194 |
| Fisher Scientific Company L.L.C. | $186 |
| Kedrion Biopharma Inc. | $150 |
| Samsung HME America, Inc. | $30 |